Tanzanian Mbeya Coffee (Coffea arabica 'Tanzanian Mbeya')
Tanzanian Mbeya Coffee (Coffea arabica 'Tanzanian Mbeya') is a highland-grown arabica cultivar containing chlorogenic acids (30.26–55.75 mg/g) and caffeine (1.16–1.78 mg/g) as its primary bioactive compounds. Chlorogenic acids exert antioxidant activity by scavenging free radicals, while caffeine stimulates the central nervous system by competitively blocking adenosine receptors (A1 and A2A subtypes).

Origin & History
Tanzanian Mbeya coffee is a cultivar variant of Coffea arabica grown in the Mbeya region of Southern Tanzania, characterized by distinctive red fruit flavor notes including strawberry and raspberry with mild acidity and hints of chocolate. The beans are typically processed using fully washed methods, which involve removing the fruit pulp and fermenting the beans before drying.
Historical & Cultural Context
The research does not contain information about traditional medicine uses of coffee in any traditional medicine system. Coffee's use in traditional medicine systems would require additional historical and ethnobotanical sources.
Health Benefits
• Contains chlorogenic acid (30.26-55.75 mg/g) with demonstrated antioxidant activity through DPPH and FRAP assays - evidence quality: in-vitro studies only • Provides caffeine (1.16-1.78 mg/g) for central nervous system stimulation through adenosine receptor antagonism - evidence quality: mechanism established but no specific clinical trials provided • Contains polyphenolic compounds including catechin, epicatechin, and anthocyanins with antioxidant properties - evidence quality: preliminary laboratory data • Rich in melanoidins (15.41-85.51 mg/g) formed during roasting with potential bioactivity - evidence quality: chemical analysis only • Source of trigonelline and volatile compounds that may contribute to bioactivity - evidence quality: compositional data without clinical validation
How It Works
Chlorogenic acids in Tanzanian Mbeya Coffee, primarily 5-caffeoylquinic acid, inhibit free radical chain reactions as measured by DPPH radical scavenging and FRAP (ferric reducing antioxidant power) assays, and may inhibit glucose-6-phosphatase to modulate postprandial glucose absorption. Caffeine (1.16–1.78 mg/g) acts as a non-selective adenosine receptor antagonist at A1 and A2A receptors, increasing dopaminergic and noradrenergic neurotransmission to produce alertness and reduced perception of fatigue. Additionally, chlorogenic acids may upregulate Nrf2-mediated antioxidant response element (ARE) pathways, though this has not been confirmed specifically for this cultivar.
Scientific Research
The provided research contains no human clinical trials, randomized controlled trials, or meta-analyses specific to Tanzanian Mbeya coffee or its health effects. Available sources focus exclusively on chemical composition and sensory characteristics rather than clinical outcomes.
Clinical Summary
Current evidence for Tanzanian Mbeya Coffee's bioactive compounds is derived from in-vitro antioxidant assays (DPPH and FRAP) and established mechanistic pharmacology for caffeine; no cultivar-specific human clinical trials have been published. The chlorogenic acid concentration range of 30.26–55.75 mg/g was determined through phytochemical profiling studies, placing it within the spectrum reported for Coffea arabica varieties generally. Broader research on green coffee bean extracts standardized to chlorogenic acids has shown modest benefits in blood pressure and glucose metabolism in small human trials (typically n=20–50), but these findings cannot be directly extrapolated to Mbeya Coffee without cultivar-specific data. The caffeine content is well-characterized mechanistically, with robust human evidence for cognitive and ergogenic effects at doses of 3–6 mg/kg body weight.
Nutritional Profile
Tanzanian Mbeya Coffee (green/roasted bean basis, per gram unless noted): Caffeine 1.16-1.78 mg/g (methylxanthine alkaloid, highly bioavailable, ~99% absorbed orally); Chlorogenic acids (CGAs) 30.26-55.75 mg/g in green beans (primarily 5-caffeoylquinic acid, 3-caffeoylquinic acid, and dicaffeoylquinic acid isomers — significantly reduced 50-70% upon roasting to ~10-20 mg/g in light-medium roast); Trigonelline 6-10 mg/g (precursor to niacin/vitamin B3, partially degraded during roasting to yield nicotinic acid); Total polyphenols approximately 35-65 mg gallic acid equivalents/g (green); Proteins 10-13% dry weight (green bean), comprising free amino acids including glutamic acid, aspartic acid, and asparagine — Maillard reaction substrates during roasting; Lipids 10-17% dry weight (primarily diterpenes cafestol and kahweol at 2-8 mg/g, which are cardioactive compounds — largely retained in unfiltered brew, removed by paper filtration); Sucrose 6-9% dry weight (green), nearly fully hydrolyzed during roasting to glucose and fructose then further degraded; Dietary fiber (as brewed beverage) negligible (<0.1 g per 240 ml serving); Potassium approximately 49-80 mg per 240 ml brewed cup; Magnesium 7-10 mg per 240 ml brewed cup; Niacin (B3) 0.5-1.0 mg per cup (from trigonelline degradation); Manganese ~0.05-0.1 mg per cup; Riboflavin (B2) trace ~0.01 mg per cup; Total antioxidant capacity (FRAP) 4.5-8.5 mmol Fe2+/L in brewed form; Bioavailability notes: CGAs are moderately bioavailable (~30-60% absorbed in small intestine, remainder metabolized by colonic microbiota to hydroxycinnamate metabolites); caffeine bioavailability near complete; cafestol/kahweol bioavailability dependent on brewing method (espresso and French press retain high levels; filtered drip removes >90%); mineral bioavailability from coffee is modest due to polyphenol-mineral complexation.
Preparation & Dosage
No clinically studied dosage ranges specific to Tanzanian Mbeya coffee are available in the research. Standard caffeine content is approximately 12 mg per gram of dry roasted coffee. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Green tea extract, L-theanine, rhodiola rosea, ashwagandha, cocoa extract
Safety & Interactions
Caffeine in Tanzanian Mbeya Coffee can cause insomnia, increased heart rate, anxiety, and elevated blood pressure, particularly at intakes exceeding 400 mg/day in healthy adults; individuals with cardiac arrhythmias or hypertension should exercise caution. Chlorogenic acids may enhance the hypoglycemic effect of antidiabetic medications such as metformin or insulin, increasing the risk of hypoglycemia when consumed in concentrated supplemental doses. Caffeine interacts with stimulant medications, MAO inhibitors, and fluoroquinolone antibiotics (which inhibit CYP1A2-mediated caffeine metabolism), potentially amplifying stimulant effects. Pregnant individuals are advised to limit caffeine to under 200 mg/day per major health guidelines, and high-dose chlorogenic acid supplements have insufficient safety data during pregnancy and lactation.